These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 21532556

  • 1. Innovative drug R&D in China.
    Qi J, Wang Q, Yu Z, Chen X, Wang F.
    Nat Rev Drug Discov; 2011 May; 10(5):333-4. PubMed ID: 21532556
    [No Abstract] [Full Text] [Related]

  • 2. Pharmaceutical sciences in 2020.
    Crommelin D, Stolk P, Besançon L, Shah V, Midha K, Leufkens H.
    Nat Rev Drug Discov; 2010 Feb; 9(2):99-100. PubMed ID: 20118959
    [No Abstract] [Full Text] [Related]

  • 3. A status report on neuroscience research, without grade inflation.
    Johnston SC, Hauser SL.
    Ann Neurol; 2006 Dec; 60(6):A9-11. PubMed ID: 17192939
    [No Abstract] [Full Text] [Related]

  • 4. Driving earlier clinical attrition: if you want to find the needle, burn down the haystack. Considerations for biomarker development.
    Peck RW.
    Drug Discov Today; 2007 Apr; 12(7-8):289-94. PubMed ID: 17395088
    [Abstract] [Full Text] [Related]

  • 5. [Partnership between drug industry and the university--innovation, proof of efficacy, drug safety].
    Weihrauch TR.
    Z Gastroenterol; 1999 Jul; Suppl 2():12-8. PubMed ID: 10472694
    [No Abstract] [Full Text] [Related]

  • 6. BIO 2006 Annual International Convention. Innovations in biotech in China and Italy.
    Tear S, Zarkowska T.
    IDrugs; 2006 Jun; 9(6):386-9. PubMed ID: 16752303
    [No Abstract] [Full Text] [Related]

  • 7. Science, medicine and... the markets.
    Pawlotsky JM.
    J Hepatol; 2006 Sep; 45(3):341-2. PubMed ID: 16854496
    [No Abstract] [Full Text] [Related]

  • 8. Clinical research: outlook from industry.
    Echols R.
    Clin Perform Qual Health Care; 1996 Sep; 4(2):113-4. PubMed ID: 10156942
    [No Abstract] [Full Text] [Related]

  • 9. Overcoming the challenges in the pharma/biotech industry.
    Graul AI, Prous JR.
    Drug News Perspect; 2007 Sep; 20(1):57-68. PubMed ID: 17332900
    [Abstract] [Full Text] [Related]

  • 10. An audience with...Marc Cluzel.
    Cluzel M.
    Nat Rev Drug Discov; 2010 Jan; 9(1):14. PubMed ID: 20043024
    [Abstract] [Full Text] [Related]

  • 11. Brand-name drug companies fail to meet R&D commitments.
    Kondro W.
    CMAJ; 2006 Aug 15; 175(4):344. PubMed ID: 16908891
    [No Abstract] [Full Text] [Related]

  • 12. Discontinued drugs in 2010: oncology drugs.
    Williams R.
    Expert Opin Investig Drugs; 2011 Nov 15; 20(11):1479-96. PubMed ID: 21955127
    [Abstract] [Full Text] [Related]

  • 13. Small study on industry trial sponsorship leads to big questions about quality and bias.
    Twombly R.
    J Natl Cancer Inst; 2007 Jul 04; 99(13):988-90. PubMed ID: 17596566
    [No Abstract] [Full Text] [Related]

  • 14. The future of clinical research.
    Vaitukaitis JL.
    Clin Res; 1991 Apr 04; 39(2):145-56. PubMed ID: 2044346
    [No Abstract] [Full Text] [Related]

  • 15. Daniel Vasella.
    Hughes B.
    Nat Rev Drug Discov; 2010 Feb 04; 9(2):98. PubMed ID: 20118958
    [No Abstract] [Full Text] [Related]

  • 16. Stepping up to the plate.
    Nat Immunol; 2008 Jan 04; 9(1):1. PubMed ID: 18087245
    [No Abstract] [Full Text] [Related]

  • 17. Biotech R&D still reeling.
    Lawrence S.
    Nat Biotechnol; 2004 Sep 04; 22(9):1068. PubMed ID: 15340460
    [No Abstract] [Full Text] [Related]

  • 18. Pharmaceutical futures: made in China?
    Cyranoski D.
    Nature; 2008 Oct 30; 455(7217):1168-70. PubMed ID: 18971994
    [No Abstract] [Full Text] [Related]

  • 19. Industrial R&D paradigm shift to vaccines.
    Maggon K.
    Biotechnol J; 2009 Apr 30; 4(4):458-61. PubMed ID: 19370719
    [No Abstract] [Full Text] [Related]

  • 20. Property rights go East.
    Nature; 2005 Nov 24; 438(7067):420-1. PubMed ID: 16306959
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.